Quick answers
- What is Cyklokapron?
- Cyklokapron is a brand name of Tranexamic acid, a prescription medicine. The FDA NDC Directory lists 1 Cyklokapron product in 1 strength and form.
- Who makes Cyklokapron?
- Pfizer holds the FDA application for Cyklokapron (NDA019281, approved December 30, 1986).
- Is there a generic or store brand of Cyklokapron?
- Yes. The FDA NDC Directory lists 14 other products with the same active ingredients, strength and form as a Cyklokapron product, 14 of them generic. Ask your pharmacist whether one is right for you.
- Has Cyklokapron been recalled?
- No recall linked to Cyklokapron products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Cyklokapron is
Each Cyklokapron product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Tranexamic acid · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| tranexamic acid 100 mg/mL injection, solution (intravenous) | Cyklokapron | 14 products, 11 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Tranexamic acid →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA019281 | Pfizer | December 30, 1986 | 1 |
Companies that list Cyklokapron
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Cyklokapron products.
- Pfizer Laboratories Div Pfizer Inc1 product
Recalls
No recall linked to Cyklokapron products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.